Studies from cohorts of patients with HIV-associated CM have shown that higher baseline concentrations of IFN-γ, TNF-α, and IL-6 in the CSF are associated with lower CSF fungal burden, faster fungal clearance on antifungal therapy, and improved survival [23–26]. The gene discussed is TNF; the disease is cutaneous mastocytosis.